scopes

Iranian Journal of Diabetes and Metabolism is a quarterly published since 2001 in Persian together with English abstracts. The main scope of this journal is to publish original basic and clinical studies in the special field of diabetes and lipid disorders. The members of the editorial board of IJDLD are specialists in the fields of endocrinology and biochemistry selected on the basis of their research background from different parts of the country as well as some international authorities in the relevant fields. 

Publishing in IJDLD is free of charge

You can publish in IJDLD free of charge: no payments are required from the Authors. IJDLD doesn’t have article submission charges nor article processing charges (APCs).

The steps toward publishing in IJDLD

The steps toward publishing in IJDLD are the following:

  • you can upload your manuscript files online (please note that, to submit articles to IJDLD's website, authors must first be registered as both readers andauthors; if you experience problems in submitting a manuscript after registering with the site, please read the step-by-step guide in this pdf) or email them to the Editor-in-Chief.
  • the Editor-in-Chief will make a first evaluation of the article;
  • if it is considered interesting, the article will be sent to 2/3 reviewers, who will evaluate it accordingly with a “single-blind peer review” procedure;
  • the article will be returned to you with the reviewers’ notes and possibly with changes to be made;
  • once you have made the corrections, the article will be forwarded to the reviewers, who will again write their opinions, requiring further corrections or giving their consent to publication;
  • once the peer review process has been completed, a layout version as a PDF file will be prepared, and the proofs will be sent to you so you can check them for the last time and answer queries that may have arisen during the layout process;
  • when you send back the proofs, you will also have to send a signed copyright agreement, where you agree to transfer the copyright to the journal’s publisher;
  • the PDF file will be published online.

Average lenght of time from author submission of manuscript to final published version of article: 3 months.

Publication Ethics and Publication Malpractice Statement

Our ethic statements are inspired by COPE’s Best Practice Guidelines for Journal Editors.

In particular:

Authorship and Contributorship

Upon publication, the corresponding author must declare that:

  • he/she is the corresponding author for this manuscript. He/she acknowledges that the corresponding author has primary responsibility for correspondence with the journal, and he/she is signing this agreement on behalf of the whole group of authors;
  • the submission has not been previously published, nor is it before another journal for consideration;
  • the manuscript is an original work and I guarantee its originality. He/she guarantees that no parts have been copied by other papers, books, websites, etc.;
  • he/she acknowledges that authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. He/she declares that each and every person listed as author meets conditions 1, 2 and 3. Moreover, he/she acknowledges that acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship;
  • all persons who qualify for authorship are listed as authors;
  • he/she acknowledges that all contributors who do not meet the criteria for authorship should be listed in an Acknowledgments section. In particular, he/she acknowledges that he should declare whether assistance was received for study design, data collection, data analysis, or manuscript preparation. He/she acknowledges that, If such assistance was available, the identity of the individuals who provided this assistance and the entity that supported it in the published article should be disclosed. He/she acknowledges that financial and material support should also be acknowledged.

Moreover, he/she declares that:

  • no assistance was given by people other than authors;
  • OR assistance was given by people other than authors and all contributors are listed in an Acknowledgments section; he/she also certifies that these persons have given him written permission to be acknowledged.

Conflict of Interest Statement and Funding Acknowledgement

In every article a declaration of interest is published.

Upon publication, the corresponding author must declare that:

  • he/she acknowledges that a conflict of interest exists when an author (or the author’s institution) has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from being negligible to having great potential for influencing judgment. Not all relationships represent true conflicts of interest. The potential for conflict of interest may exist regardless of whether a person believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, and paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and science itself. However, conflicts may occur for other reasons, such as personal relationships, academic competition, and intellectual passion.

The corresponding author must also certify that:

  • all funding, other financial support, and material support for this work are clearly identified in the manuscript.

Moreover, the corresponding author must declare that:

  • no conflicts of interest exist;
  • OR conflicts of interest exist and are clearly indicated at the end of the article.

This policy is based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated April 2010" made by the International Committee of Medical Journal Editors.

Human Rights: Protection of Research Participants and Informed Consent

Considering human experimentation, the authors should write whether the procedures followed were in accordance with the ethical standards of the institutional committee on human experimentation.

If no formal ethics committee is available, the authors should indicate whether the procedures were compliant with the Helsinki Declaration as revised in 2008.

Patients have a right to privacy that should not be violated without informed consent. Identifying information (e.g., names, initials, or hospital numbers) should not be published in written descriptions, photographs, or pedigrees unless the information is needed for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication.

When informed consent has been obtained, the authors should indicate it when submitting the article.

This policy is based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated December 2013" made by the International Committee of Medical Journal Editors.

Animal Rights

Considering experiments on animals, authors should indicate whether institutional and/or national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare.

This policy is based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated December 2013" made by the International Committee of Medical Journal Editors.

Self-archiving

Authors can archive the 

published paper:

  • publisher's version (the PDF published on the official journal's website) must be used;
  • authors can archive it immediately (without any period of embargo);
  • authors can archive it on their personal websites, institutional website and institutional repositories;
  • authors are kindly encouraged to provide a link to the journal's website.

Self-archive of preprint and postprint is not permitted instead.

IJDLD's self-archiving policy is indexed in SHERPA/RoMEO.

Screening for plagiarism

The journal staff has a policy of screening for plagiarism. All articles in this publication are original: the content (either in full or in part) in each article has not been knowingly republished without specific citation to the original release. Plagiarism checker is applied randomly to the majority of the papers submitted.

Copyright and publishing rights

Regarding copyright, before publication, Authors declare that, in consideration of the action of IJDLD in reviewing and editing their submission, they transfer, assign, or otherwise convey all copyright ownership, including any and all rights incidental thereto, exclusively to the IJDLD Publisher (Hygeia Press di Corridori Marinella).

Authors have the opportunity to reuse figures, tables and selected text up to 250 words from their article as finally published, providing that full and accurate credit shall be given to publication in IJDLD and that modifications are noted (otherwise no changes may be made).

Disclaimer

Disclaimer. Care has been taken to confirm the accuracy of the information presented and to describe generally accepted practices. However, the authors, editors, and publisher are not responsible for errors or omissions or for any consequences from application of the information in the journal and make no warranty, expressed or implied, with respect to the currency, completeness, or accuracy of the contents of this publication.

Drug dosage. The authors, editors and publisher have exerted every effort to be certain that drug selection and dosage set forth in this issue are in accordance with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new or infrequently employed drug.

All rights reserved. All materials are protected by Italian law and by international conventions. No part of this work may be translated into other languages, reproduced or utilized in any form or by any means without the prior written permission of the publisher.


View: 7666 Time(s)   |   Print: 193 Time(s)   |   Email: 2 Time(s)   |   0 Comment(s)

© 2015 All Rights Reserved | Iranian Journal of Diabetes and Metabolism

Designed & Developed by : Yektaweb